Phase III trial of pegaptanib (Macugen) compared with pan-retinal laser photocoagulation (PRP) in patients with active proliferative diabetic retinopathy (PDR)
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2009
At a glance
- Drugs Pegaptanib (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 05 Nov 2009 New trial record.